ADAM17 Supports Disinhibition of Pre-sympathetic Glutamatergic Neurons Through Microglial Chemotaxis
Neuroscience Bulletin · 2026
DOI: 10.1007/s12264-025-01471-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroscience Bulletin, 2026. Verfasst von Jiawei Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China. Hauptthemen laut MEDLINE: ADAM17 Protein, Chemotaxis, Microglia, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
A disintegrin and metalloprotease 17 (ADAM17) is a membrane-bound enzyme that cleaves cell-surface proteins. Here, we discovered that neuronal ADAM17-mediated signaling supports the reduction of inhibitory presynaptic inputs to the pre-sympathetic glutamatergic neural hub, located in the paraventricular nucleus of the hypothalamus (PVN), upon stimulation by angiotensin II (Ang-II). For Ang-II-induced disinhibition, targeting microglial migration had an effect similar to ADAM17 knockout in glutamatergic neurons. Ang-II promoted neuron-mediated chemotaxis of microglia via neuronal CX3CL1 and ADAM17. Inhibiting microglial chemotaxis by targeting CX3CR1 abolished the Ang-II-induced microglial displacement of GABAergic presynaptic terminals and significantly blunted Ang-II's pressor response. Using conditional and targeted knockout models of ADAM17, an increase in the contact between pre-sympathetic neurons and reactive microglia in the PVN was demonstrated to be neuronal ADAM17-dependent during the developmental stage of salt-sensitive hypertension. Collectively, this study provides evidence that neuronal ADAM17-mediated microglial chemotaxis facilitates the disinhibition of pre-sympathetic glutamatergic tone upon hormonal stimulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
- Department of Cardiology, Xi'an Jiaotong University Second Affiliated Hospital, Xi'an, 710004, China.
- Department of Pathogenic Microbiology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
- Institute of Medical Research, Northwestern Polytechnical University, Xi'an, 710072, China.
- Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
- SouthEast Louisiana Veterans Health Care System, New Orleans, LA, 70119, USA.
ORCID-Profile: Jiaxi Xu
Förderung
- NHLBI NIH HHS
Zitieren
APA
Wang, J., Qiu, Z., Han, Y., Wu, H., Yuan, M., Liu, Y., Wang, H., Yuan, S., Gao, D., Sun, L., Chen, X., Lazartigues, E., Li, F., Yang, R., & Xu, J. (2026). ADAM17 Supports Disinhibition of Pre-sympathetic Glutamatergic Neurons Through Microglial Chemotaxis. Neuroscience Bulletin. https://doi.org/10.1007/s12264-025-01471-8
Vancouver
Wang J, Qiu Z, Han Y, Wu H, Yuan M, Liu Y, et al. ADAM17 Supports Disinhibition of Pre-sympathetic Glutamatergic Neurons Through Microglial Chemotaxis. Neuroscience Bulletin. 2026. doi:10.1007/s12264-025-01471-8
BibTeX
@article{Wang2026,
author = {Wang, Jiawei and Qiu, Zihan and Han, Yue and Wu, Hanxue and Yuan, Miao and Liu, Yan and Wang, Huichao and Yuan, Shenglan and Gao, Dengfeng and Sun, Lina and Chen, Xingjuan and Lazartigues, Eric and Li, Fanni and Yang, Rui and Xu, Jiaxi},
title = {ADAM17 Supports Disinhibition of Pre-sympathetic Glutamatergic Neurons Through Microglial Chemotaxis},
journal = {Neuroscience Bulletin},
year = {2026},
doi = {10.1007/s12264-025-01471-8}
}
EUVIMED